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1. Introduction 
The phenomenon of double-stranded RNAs (dsRNAs)-mediated gene silencing or RNA 
interference (RNAi] was first discovered in nematode Caenorhabditis elegans by Andrew Fire 
and Craig Mello in 1998 [1]. This great discovery gives rise to a fast-growing field and leads 
to the identification of novel RNAi pathways by which small interference RNAs (siRNAs) 
regulate gene expression and gene functions. Collective evidence suggests that the RNAi 
pathway is conserved in many eukaryotes and this pathway can be triggered by either 
exogenous or endogenous small interference RNAs. Exogenous dsRNAs (e.g. a virus with 
an RNA genome) are typically required a membrane transporter for dsRNA uptake into the 
cytoplasm, while endogenous small interference RNAs (e.g. microRNAs) are encoded in the 
genome. The precursors of both dsRNA and microRNA are first cleaved into short 
interference RNAs by a ribonuclease III (RNaseIII) enzyme, Dicer. Then these short 
interference RNAs initiate RNAi process when interacting argonaute proteins in the RNA-
induced silencing complex (RISC). The small interference RNAs normally consist of 20~30 
nucleotides. They can repress the transcription of message RNAs containing homologous 
sequences by either post-transcriptional gene silencing (PTGS) or transcriptional gene 
silencing (TGS) [2].  
In their Nature paper, Fire and Mello wrote: ‘Whatever their target, the mechanisms 
underlying RNA interference probably exist for a biological purpose’. Indeed, it’s been 
shown that there are numerous cellular and physiological functions linked to RNAi [1]. For 
example, viral defense has been proposed to be the primary function of RNAi in both plants 
and flies [3]. In plants, virus infection could trigger sequence-specific gene silencing [4]. 
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Plant RNAi forms the basis of virus induced gene silencing (VIGS), proofed from the genetic 
links between virulence and RNAi pathways [5-6]. On the other hand, endogenous 
microRNAs (about 1000 microRNAs in human genome) [7] play essential roles in 
controlling cellular functions. For example, the early discovered microRNAs, such as lin-4 
and let-7 of C. elegans, were identified to regulate developmental timing [8-9]. Following the 
identification of let-7 in C. elegans and later in fruit flies Drosophila melanogaster (hereafter I 
will refer it as ‘Drosophila’), it is soon realized that let-7 belongs to a conserved microRNA 
family in many species. Besides the regulation on development, many microRNAs have 
been found to control key physiological processes, such as lipid metabolism [10] and insulin 
sensitivity [11]. The dysregulation of microRNA may result in many human diseases. A 
mutation in the seed region of miR-96 causes hereditary progressive hearing loss [12]. Some 
microRNAs have also been linked to cancer [13]. 
Soon after the discovery of dsRNA-mediated RNAi in 1998, gene silencing through RNAi 
was quickly developed as a powerful tool or technique in functional genomics studies. 
Comparing to forward genetics tools (e.g. EMS-induced mutagenesis screens), RNAi is one 
of effective reverse genetic tools, especially for non-model organisms and mammalian 
systems in which genetics is difficult. The advantage of applying RNAi in function studies 
becomes even more apparent when the whole genome sequences of model organisms (e.g. 
C. elegans and Drosophila) were completed in the late 90’s and early 2000’s [14-15]. In the 
post-genome era, utilizing high-throughput platforms and innovative bioinformatics tools, 
many large-scale RNAi screens has been successfully applied for the discovery of novel 
gene function associated with many important aspects of biology such as signal 
transduction [16], cell proliferation [17], metabolism [18], host-pathogen interactions [19] 
and aging [20-21]. Through these genome-wide RNAi screens, we have gained new insights 
on novel players in many key biological processes and complexity of cellular signaling 
networks. Cell-based and in vivo RNAi screen has been extensively reviewed in the past [22-
23].In this book chapter, I will focus on the recent development of high-throughput RNAi 
screen for functional analysis in cultured cells and in vivo systems, as well as its applications 
on functional genomics and the discovery of novel therapeutic drug and agricultural targets.  
2. RNAi screen methods 
Despite the challenges from off-target effects and false discovery during the data analysis, 
genome-wide RNAi screens have benefitted from improved RNAi delivery methods, 
automated high-content image system and robust statistic analysis [23]. In the following 
section, I will compare the different reagent delivery methods, read-out assays, and off-
target effects in various systems and platforms. I will also provide several examples from 
recent studies using genome-wide RNAi screen in cultured cells. 
2.1. Cell-based RNAi screen 
Genome-wide RNAi screen in cultured cells or primary cells provides an opportunity to 
systematically interrogate gene function. Now large-scale RNAi screens have been routinely 
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performed in Drosophila and mammalian cultured cells, as well as in primary cells. RNAi 
screen with Drosophila and mammalian cells has already led to important discovery in a 
wide variety of topics, including signal transduction, metabolism and cancer [22]. In general, 
a cell-based RNAi screen involves four major steps: [1]. RNAi library selection; [2]. 
Incubation of appropriate cell lines with RNAi reagents that are pooled or individually 
arrayed into 96- or 384-well plates; [3]. After additional treatments (if applicable), cells are 
subjected to the automated plate reader to quantify the specific readout (e.g. changes in cell 
morphology or fluorescence and luminescence signals from study targets); [4]. High-content 
image data analysis.  
RNAi library and reagent delivery methods. Since the completion of C. elegans genome 
sequencing in 1998 [14], more and more eukaryotic genomes have been sequenced, which 
makes it possible to produce whole-genome RNAi libraries for functional genomics studies. 
Typically, long dsRNAs are used for RNAi screen in Drosophila cells, while synthetic siRNAs 
or vector-based short hairpin RNAs (shRNAs) are commonly used for mammalian cells [24]. 
Several Drosophila cell lines (e.g. S2 and Kc167) can directly take up dsRNA without the help 
of transfection reagents, which provides great advantages in high-throughput RNAi screens 
[25-26]. For mammalian cells, RNAi reagents are transient transfected into the cells. 
Therefore, not only the variation of transfection efficiency among cell lines and experimental 
replicates will affect the RNAi knockdown effects, but also the doubling time will affect the 
duration of gene silencing. Compared to synthetic siRNA method, vector-based shRNA 
technology combining with viral delivery methods provides robust gene silencing for a 
longer period of time. Besides, vector-based shRNA approaches make it possible to build 
renewable and cost-effective RNAi libraries. 
Now RNAi libraries are available for many model organisms, especially Drosophila and 
mammalian cells (Table. 1). These RNAi libraries normally contain the collection of RNAi 
reagents (dsRNAs, siRNAs and shRNAs) for all annotated genes in the genome. In the RNAi 
libraries, typically there are several different dsRNAs or siRNAs corresponding to each 
gene. For example, The GeneNet™ Human 50K siRNA library from System Biosciences 
contains 200,000 siRNA templates targeted to 47,400 human transcripts (~4 different siRNA 
sequences per transcript) (http://www.systembio.com/rnai-libraries). In Drosophila DRSC 2.0 
RNAi collection, there are 1-2 dsRNAs per gene, including genes that encode proteins and 
non-coding RNAs (http://www.flyrnai.org). Beside genome-wide libraries, many pathway 
libraries or sub-libraries are also available for silencing specific signal pathways or multi-
gene families (e.g. kinases & phosphatases library, G protein-coupled receptor library, 
apoptosis & cell cycle library, etc.).  
Read-out assays. Together with luminescent and fluorescent reporter-based image analysis 
and improved high-content image processing packages (e.g. CellProfiler [27] , various read-
outs are used in RNAi screens, including the expression changes in target genes or proteins, 
post-translation modification, metabolic processes, and changes in sub-cellular localization 
patterns. Most of these read-outs are based on the measurement of the intensity of 
luminescent and fluorescent reporters. Although RNAi screens for cell morphology (e.g. 
cytoskeletal organization and simple cell shape) have been previously reported [28-30], 
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complex cell shape and structure-based read-outs still remain problematic. Frequently, 
additional treatments are performed before the read-out assays in RNAi screens. These 
treatments can be drugs, pathogens, or stress inducers [31-33].  
 
Name Species Type Link 
Genome-wide RNAi libraries 
Drosophila RNAi 
Screen Center 
Fruit fly dsRNA www.flyrnai.org/ 
DKFZ Genome RNAi Fruit fly dsRNA www.genomernai.org 
Open Biosystems Human, mouse siRNA , shRNA 
www.openbiosystems.com/R
NAi 
Sigma Human, mouse siRNA , shRNA www.sigmaaldrich.com 
SBI Human, mouse siRNA , shRNA 
http://www.systembio.com/r
nai-libraries 
Pre-defined or custom RNAi libraries 
Ambion Human, mouse siRNA , shRNA www.invitrogen.com/sirna 
Qiagen Human, mouse siRNA , shRNA www.qiagen.com 
Dharmacon Human, mouse siRNA , shRNA www.dharmacon.com 
The Netherlands 
Cancer Institute (NKI) 
Human shRNA 
www.lifesciences.sourcebiosc
ience.com/ 
Table 1. List of RNAi libraries used in cell cultures 
Off-target effects. False positive or false negative results are commonly associated with 
high-throughput studies, including genome-wide RNAi screens [34]. The false discovery in 
RNAi screens can be caused by instrument errors, statistical noises, low knock-down 
efficiency and off-target effects of RNAi reagents. Off-target effects of RNAi reagents usually 
include: [1]. A general interference on endogenous RNAi pathway; or [2] Sequence-
dependent effects on the expression of non-target genes. In order to minimize off-target 
effects, it is suggested to perform sufficient replication experiments and choose two or more 
RNAi reagents that target different regions of the coding sequences. Sequence-dependent 
off-target effects can be avoided by selecting sequences that do not contain 19 or more base 
pairs of contiguous nucleotide identity to other genes in the genome [34-35]. 
Recent cell-based RNAi screen studies. Genome-wide RNAi screens have been primarily 
conducted in both Drosophila and mammalian cultured cells (Reviewed in [22]. These 
screens are involved in studies on a variety of biology processes, such as signal 
transduction, metabolism, cancer, stem cells. The cell-based RNAi screens have yielded 
tremendous amount of novel discoveries and greatly promoted our understanding on many 
basic biological processes, molecular functions and complexity of cellular networks. New 
findings from genome-wide RNAi screens have led to the identification of novel 
components of canonical signaling transduction pathways, such new players of ERK 
pathway [16] and phosphorylation networks regulating JUN NH2-terminal kinase (JNK) 
pathway [36]; the role of S1pr2 gene (Sphingosine-1-phosphate receptor 2) in insulin 
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signaling [37]; novel modulators of p53 pathway [38]; and key genes that are essential for 
the proliferation of cancer cells [17]. Recently, an integrative approach with RNAi screen 
and whole genome structural analysis identified IKBKE kinase as a breast cancer oncogene 
[39]. Beside its application in studying signaling pathways, cell-based RNAi screens are also 
performed to understand the cellular responses to pathogens. For example, recent RNAi 
screens identified novel host factors that are required for dengue virus propagation [40] and 
influenza virus replication [41]. I will discuss more detail on some of genome-wide RNAi 
screens in section. 3. 
2.2. In vivo RNAi screen 
Many complex phenotypes, such as aging, cannot be tested in a cell-based assay, thus in vivo 
functional analysis is required. In vivo RNAi screen is one of such approaches to study gene 
function at an organism level. C. elegans and Drosophila are two model organisms that are 
commonly used in in vivo RNAi screens. Although ex vivo RNAi screens have been done by 
introducing shRNA-transfected cells into mice [42-43], direct in vivo RNAi screen in mice is 
still under development. Most importantly, in vivo RNAi makes it possible for gene function 
studies in species lacking classical genetic tools, even including species without whole 
genome sequences (Usually next-generation sequencing is used to identify gene coding 
sequences and to facilitate RNAi reagent design and production).    
In vivo genome-wide RNAi screen was first reported in C. elegans [44]. In C. elegans, dsRNA-
mediated RNAi effects are systemic and heritable [1], although gene knockdown is less 
efficient in the nervous system than in other tissues. In vivo genome-wide RNAi screens have 
been performed in the studies of aging [20-21, 45-46], metabolism [47] and microRNA 
pathways in C. elegans [48]. It is relatively easy to deliver dsRNA into C. elegans. Typically, 
dsRNAs are introduced to worms by soaking the animals in dsRNA solution [49], by injection 
of dsRNA [1], or by feeding the animals dsRNA-expressing bacteria [44]. The last method is 
commonly used to generate genome-wide RNAi libraries. These C. elegans RNAi libraries are 
now available from Ahringer lab RNAi collection and Open Biosystems (Table. 2).  
In contrast, dsRNA feeding does not appear to work for gene silencing in Drosophila, while 
RNAi via injection of dsRNA is effective only in certain embryonic stages. Therefore, 
transgenic RNAi approach has been developed to express a double-stranded ‘hairpin’ RNA 
from a transgene. In Drosophila, RNAi is cell-autonomous, so that gene silencing can be easily 
performed in tissue- and spatial-specific manner by using the binary GAL4/UAS expression 
system. Currently, there are three groups that have generated genome-wide transgenic RNAi 
Drosophila stains [50] (Table. 2). These transgenic RNAi stains are all expressing inverted-
repeat hairpin RNAs once crossing to appropriate Gal4 drivers. Recently, it’s been shown that 
small hairpin RNAs (~19 nt) can trigger stronger gene inactivation than long hairpin RNAs. 
Therefore new constructs expressing small hairpin RNAs were generated to produce second 
generation of transgenic RNAi Drosophila stains at Harvard medical school (Table. 2). In the 
past several years, a number of genome-wide RNAi screens in Drosophila have been conducted 
to study the major signaling pathways [51], as well as many important disease models [52-55].  
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For example, a genome-wide obesity gene screen revealed hedgehog signaling as one of major 
adipose tissue regulators [18], while genome-wide Parkinson’s disease modifier screen 
identified novel Park and/or Pink1-interacting genes [56]. In the following section, I will discuss 
some of these RNAi screens in more detail. 
 
Name Species Type Link 
Ahringer lab RNAi 
Library at Geneservice 
Nematode Bacterial clone 
www.lifesciences.sourcebiosc
ience.com/ 
Open Biosystems Nematode Bacterial clone 
www.openbiosystems.com/R
NAi/ 
Transgenic RNAi 
project at Harvard 
Medical School 
Fruit fly 
Long dsRNA, 
Short shRNA 
www.flyrnai.org/TRiP-
HOME.html 
Vienna Drosophila 
RNAi Center 
Fruit fly Long dsRNA stockcenter.vdrc.at 
NIG-FLY Fruit fly Long dsRNA 
http://www.shigen.nig.ac.jp/f
ly/nigfly/ 
Table 2. List of RNAi libraries used for in vivo systems 
2.3. Advantage and limitation of cell-based and In vivo RNAi screens 
Unlike forward genetic screens where mutations are randomly generated, RNAi screens 
provide a fast way to link phenotypes of interest to a precise gene. Beside, RNAi screens are 
generally performed in a genome-wide scale which brings us a comprehensive view of gene 
functions. Both cell-based and in vivo RNAi screens are highly effective and less labor-
intensive on the discovery of gene functions when compared to traditional mutagenesis 
screens. Furthermore, cell-based and in vivo RNAi can be applied to study gene functions in 
species lacking classical genetics tools. 
In the past decade, genome-scale in vitro RNAi screens have been successfully applied for gene 
discovery and understanding fundamental biological processes and cellular signal pathways. A 
variety of RNAi libraries for cell-based RNAi screens have been developed for both invertebrate 
and vertebrate systems. Nowadays cell-based RNAi screens are relatively less expensive, and 
have become a fast and user-friendly platform for functional genomics studies. On the other 
hand, complex phenotypes that cannot be analyzed in cell-based RNAi screens, are normally 
directly studied in vivo. When compared to forward genetic screens where mutations are 
occurred in every cell and many mutations lead to developmental defect or lethality, in vivo 
RNAi screens can be performed in various developmental stages and different tissues. This is 
especially useful when adult-specific functions of target genes are studied and these genes are 
essential for the development. Currently, most of in vivo RNAi screens are conducted in  
C. elegans and Drosophila due to the availability of a tremendous amount of resources  
and advanced genetic tools. In contrast, in vivo RNAi screen in mice is still in early stage. 
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3. Application of RNAi screen 
Genome-wide RNAi screen has greatly advanced our understanding on many fundamental 
biology problems, from signaling transduction pathways to complex phenotypes. 
Furthermore, the results from RNAi screen can be used to design future theroputic drugs 
and crop protection reagents. In the following section, I will discuss several applications 
using RNAi screen approaches. 
3.1. Deciphering cellular signaling pathways and complex traits  
RNAi is one of the most powerful tools in functional genomics studies. Genome-wide RNAi 
screens have accelerated our understanding of basic biological functions and cellular signal 
networks, as well as the novel modulators of diseases. Follow-up experiments are usually 
performed to confirm the screen results and further study the underlying molecular 
mechanisms of identified genes or pathways. In vivo RNAi screens have also been 
conducted to study complex traits, such as aging. C. elegans is the primary model organism 
used in longevity gene screen, not only because high-throughput RNAi experiments are 
relatively easy to do in C. elegans, but also because of its short lifespan [57]. 
3.1.1. Understanding signaling pathways 
Our understanding on canonical signal pathways is rapidly evolving and many new 
components or modulators are being identified with the help from improved technologies, 
including genome-wide RNAi screen. In the past decade, RNAi screens have been applied 
for deciphering many classical signal pathways, such as Notch, Wnt, and ERK signalings. 
Receptor tyrosine kinases (RTKs) are probably one of most critical protein families that 
regulate development, cell proliferation and growth. One of RTK families, insulin signaling 
plays important roles in controlling metabolism and growth. Disrupted insulin signaling 
leads to many human diseases, such as diabetes. To facilitate the underlying mechanism of 
diabetes and identify novel components and modulators of the insulin signaling pathway, a 
RNAi screen was conducted using 3T3-L1 adipocytes [37]. About 313 obesity and diabetes 
related genes were selected in the RNAi screen. The release of free fatty acid (FFA) was used 
as a read-out, since insulin-dependent FFA release is an indicator of insulin resistance. This 
screen showed that RNAi against 126 candidate genes resulted in significant changes of FFA 
release. After future filtering, S1pr2 gene was identified as one of key regulators of insulin 
signaling. Increased plasma insulin levels were detected in male S1pr2 -/- knockout mice, 
suggesting there is a potential link between S1pr2 and insulin resistance [37]. 
One of RTK downstream effectors is ERK signaling pathways. Misregulated RTK/ERK 
signaling leads to developmental disorder and many human diseases (e.g. cancer). A recent 
RNAi screen study using Drosophila cell lines has identified 331 regulators of ERK pathway, 
suggesting a number of integrated signal pathways in the regulation of fine-tuned ERK 
signaling [16]. In this study, fluorescently-conjugated phospho-ERK antibodies were used to 
monitor the changes of phosphorylated ERK upon insulin stimulation, which is the first 
time that a RNAi screen uses post-translation modification as a read-out assay. 
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3.1.2. Identification of longevity genes 
Aging is one of the complex traits that are controlled by a large number of genes or the 
interaction between multiple genes/pathways. The first longevity pathway, insulin/ IGF-1 
pathway, was identified in C. elegans in early 90’s [58]. Following studies have shown that 
TOR (Target of Rapamycin) [59] and AMP kinase signaling [60] are also involved in 
longevity regulation. To explore other potential longevity assurance genes/pathways, two 
systematic RNAi screens for longevity genes were independently conducted at almost the 
same time in C. elegans. [45-46]. Both groups used the Ahringer bacterial RNAi libraries, 
although they chose different worm strains in the RNAi screen. Initially, the maximum 
lifespan of each RNAi clone was monitored, due to the tremendous work on the large-scale 
lifespan screen. In one screen, 89 genes were identified to be involved in lifespan regulation. 
These candidate genes encode diverse biological functions, including metabolism, 
mitochondrial functions, signal transduction, protein turnover, and so on. In contrast, 29 
genes were identified in another screen. Although both groups are able to re-discover the 
genes in insulin/IGF-1 signaling, only three newly identified genes are shared by these two 
screens. This may be due to the different worm stains used in these two screens, plus high 
level of false positive/negative hits and off-target effects. Knockdown of these three genes 
led to robust lifespan extension [57].  
Although genome-wide RNAi screens for longevity genes have not been reported in other 
species, large-scale genetic screens were performed recently. A screen of 564 single gene 
deletion strains was conducted to identify longevity genes in budding yeast [59]. Deletion of 
10 genes led to extended replicative lifespan. Among them, many genes are involved in TOR 
pathway, suggesting a link between nutrient sensing and longevity. Recently, a large-scale 
misexpression screen for Drosophila longevity genes was reported. In this screen, a total of 15 
longevity genes were identified, including genes involved in autophagy, mRNA synthesis, 
intracellular vesicle trafficking and neuroendocrine regulation [61]. With more longevity 
gene screens from other species, a cross-species comparison of these large-scale screens may 
provide us a list of conserved genes/pathways in regulating longevity. 
3.2. Identification of therapeutic drug targets 
A number of genome-wide RNAi screens have led to the identification of novel modulators 
of human diseases. RNAi screens have become an effective tool to identify and validate 
drug targets and to enhance novel drug discovery. On the other hand, RNAi-based 
therapies have been developed to target viral infection, cancer, cardiovascular disease and 
neurodegenerative diseases using specific shRNAs, although we should always keep in 
mind that there are some drawbacks and concerns of this technology, such as off-target 
effects, activation of endogenous RNAi pathways, individual genetic variation.   
Traditional cancer drug discoveries still focus on a handful of known oncogenes. It remains 
a key challenge in identifying new targets. Application of genome-wide RNAi screens in 
novel target discovery greatly enhanced cancer drug discovery. In the past few years, 
several RNAi screens were performed using cancer cell lines to explore the essential genes 
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that are required for survival and proliferation of cancer cells. One of these studies 
identified more than 250 genes are essential for the proliferation of cancer cells [17]. In the 
same study, four genes were implicated in the response of cancer cells to tumoricidal agents 
(e.g. imatinib). Several similar screens on drug sensitivity have led to the identification of 
cancer-associated genes, e.g., ACRBP, TUBGCP2, and MAD2 in breast cancer [62]. 
Combining RNAi screen and other genomic tools (e.g. SNP array, aCGH, and SAGE data 
analysis), a recent study identified IKBKE kinase as a breast cancer oncogene [39]. This 
discovery could lead to the development of pharmaceutical inhibitors that block activity of 
IKBKE kinase in breast cancer. 
Metabolic syndrome, such as obesity, can increase the risk of developing cardiovascular 
disease and diabetes. However, the underlying molecular mechanisms are far from clear. To 
understand how adiposity is regulated in Drosophila, an in vivo genome-wide RNAi screen 
was reported recently. In this study, transgenic RNAi lines corresponding to 10,489 distinct 
open reading frames were used in RNAi screen. Tissue-specific gene inactivation for 500 
candidates identified from the first screen was further tested. This study reveals hedgehog 
signaling as one of major adipocyte regulators [18]. To test whether hedgehog signaling 
plays any role in mammalian adipose tissue, mutant mice were generated to activate 
hedgehog in adipocytes. Activation of hedgehog in mice adipose tissues resulted in a 
dramatic loss of white fat compartments (but not brown) by directly blocking differentiation 
of white adipocytes. These results support the idea that white and brown adipocytes are 
derived from distinct precursor cells. Interestingly, glucose tolerance and insulin sensitivity 
remained normal in mutant mice. This suggests that modulating hedgehog signaling can 
reduce lipid accumulation in white adipose tissue, while maintain a fully functional brown 
adipose tissue. Since it has been suggested that functional brown adipose tissue represents a 
potent therapeutic target for obesity control, novel adiposity regulators (e.g. hedgehog 
signaling) will be developed as obesity drug targets in the near future. 
3.3. Agricultural applications 
Initially, it’s believed that systemic RNAi is a unique feature in worms, until this idea was 
tested in insect species other than Drosophila. The first systemic RNAi in insects was 
reported in the red flour beetle, Tribolium castaneum [63]. Injection of dsRNA for bristle-
forming gene, Tc-achaete-scute (Tc-ASH), resulted in bristle loss phenotype. Following this 
study, it was discovered that systemic RNAi via dsRNA injection works in many insect 
species, including mosquitoes [64], honey bees [65], aphids [66], termites [67], etc. Therefore 
RNAi became a useful tool in functional genomics studies in many non-model insect 
species, especially those economically important ones. 
In 2007, two breakthrough studies described the technology on pest control through feeding 
transgenic plant expressing dsRNA [68-69]. It is the first evident to show RNAi can be used 
as a potential pest control strategy for crop protection and feeding RNAi works in certain 
insect group just like worms. In these studies, initially a list of potential target genes were 
chosen and dsRNAs against target genes were synthesized in vitro and mixed with artificial 
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diet. RNAi for several target genes results in larval growth arrest and lethality. Next, 
transgenic plant was engineered to produce dsRNA against genes whose inactivation results 
in strong RNAi response. Such genes include V-type ATPase A in western corn rootworm 
and cytochrome P450 (CYP6AE14) in cotton bollworm. These results provide strong 
evidence to support the feasibility of using RNAi in pest control and crop protection. 
Recently, feeding RNAi was also demonstrated in termites [67]. Feeding on cellulose disks 
soaked with dsRNA against digestive cellulose enzyme and hexamerin storage protein 
caused reduction in termite fitness and increased mortality. This study opened a new way 
for termite control using feed RNAi technology combining with a bait system. Although 
developing RNAi-based pest control approach is still at early stage and it is not as effective 
as current crop protection technology (e.g. Bacillus thuringiensis (Bt) toxin), RNAi will 
provide an alternative strategy for the future pest management. 
3.4. A case study: Large-scale GPCR RNAi screen for novel pesticide target 
discovery 
The G protein-coupled receptors (GPCRs) belong to the largest superfamily of integral cell 
membrane proteins and play crucial roles in physiological processes including behavior, 
development and reproduction. About 1-2% of all genes in an insect genome code for 
GPCRs. Whole genome sequencing identified about 200 GPCRs in Drosophila and 276 
GPCRs in African malaria mosquito, Anopheles gambiae. Currently, there is not a commercial 
insecticide that targets GPCR. The red flour beetle, T. castaneum is one of the worldwide 
stored product pests. The genome of T. castaneum has been sequenced in 2008 [70], which 
offers great opportunities for the studies on functional genomics and the identification of 
targets for pest control. In one recent study [71], 111 non-sensory GPCRs were annotated 
from the beetle T. castaneum genome. To discover potential GPCRs as pesticide targets, a 
large-scale RNAi screen was performed by injecting dsRNA into developing larvae. The 
outline of this study is shown in Figure. 1. In this study, eight GPCRs were found involved 
in larval growth, molting and metamorphosis. The identified GPCRs may serve as potential 
insecticide targets for controlling T. castaneum and other related pest species. 
In this GPCR RNAi study [71], 111 annotated T. castaneum GPCRs were classified into four 
different families based on conserved domain prediction program: Class A, Rhodopsin-like 
receptor; Class B, Secretin receptor-like; Class C, Metabotropic glutamate receptor-like and 
Class D, Atypical GPCRs. In summary, there are 74 Rhodopsin-like GPCRs, 19 Secretin 
receptor-like GPCRs, 11 Metabotropic glutamate receptor-like GPCRs, and 7 Atypical 
GPCRs. Rhodopsin-like GPCR family contains 20 biogenic amine receptors, 42 peptide 
receptors, four glycoprotein hormone receptors and one purine receptors.  
A large-scale GPCR RNAi screen was then conducted by injecting dsRNA for 111 T. 
castaneum GPCRs into one-day-old final instar larvae. Mortality and development defects of 
dsRNA injected insects were recorded every 2-3 days until adult eclosion. This screen 
identified 12 GPCRs that effect growth and development. Among 12 GPCRs identified there 
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are biogenic amine receptor (TC007490/D2R), peptide receptors (TC013945/CcapR, 
TC012493/ETHR, TC004716 and TC006805), and protein hormone receptors 
(TC008163/bursicon receptor and TC009127/glycoprotein hormone-like receptor).  Silencing 
of genes coding for four GPCRs (TC012521/stan, TC009370/mthl and TC001872/Cirl) in Class 
B and two GPCRs (TC014055/fz and TC005545/smo) in Class D also caused severe mortality 
(Table. 3). DsRNA-mediated knockdown for eight GPCRs caused more than 90% mortality 
after dsRNA injection. Interestingly, RNAi for one of the GPCRs, dopamine-2 like receptor 
(TC007490), resulted in high lethality during early larval stage. In Drosophila, dopamine-2 
like receptor (D2R) is one of the genes highly expressed in head and brain 
(http://www.flyatlas.org/) and D2R RNAi flies with reduced D2R expression show 
significantly decreased locomotor activity (Draper et al. 2007). Since TC007490/D2R RNAi 
beetles died during the larval stage, TC007490/D2R might be playing a critical role in the 
growth and development of beetle larvae by modulating neuronal development and 
locomotor activity as reported in D. melanogaster. Collectively, the RNAi screen in T. 
castaneum has provided useful information and it has also been proven to be a nice model 
system for future pesticide screen. 
 
 
Figure 1. The outline of GPCR RNAi screen in T. castaneum 
Beside mortality, RNAi for eight GPCRs also resulted in severe developmental arrest and 
ecdysis failure, including recently characterized bursicon receptor [72]. Interestingly, the 
majority of insects injected with TC007490/D2R dsRNA was not able to molt to the pupal 
stage and died during the larval stage. Only, a few larvae injected with TC007490/D2R 
dsRNA were able to reach quiescent stage (a non-feeding prepupal stage, about 96 hr after 
ecdysis into final instar), suggesting that this gene may play an important role during larval 
T. castaneum GPCR prediction through BLAST search 
↓ 
dsRNA design and synthesis [300~500 bp] 
↓ 
Injection of dsRNA to T. castaneum larvae 
↓ 
Phenotypic data collection 
[Development arrest & ecdysis failure] 
↓ 
Select positive hits for second run of RNAi screen 
 
Functional Genomics 106 
growth and development rather than molting and metamorphosis. In contrast, most of the 
insects injected with TC001872/Cirl dsRNA entered the quiescent stage and died during this 
stage. About 40% of the insect injected TC001872/Cirl dsRNA were able to molt to the pupal 
stage and eventually died during the early pupal stage. The majority of insects injected with 
TC012521/stan dsRNA was not able to complete adult eclosion and died during pharate 
adult stage. Interestingly, TC014055/fz and TC009370/mthl RNAi caused an arrest in both 
larval-pupal and pupal-adult ecdysis, suggesting that they may play important roles in the 
regulation of ecdysis behavior. In contrast, insects injected with TC009370/mthl dsRNA 
were arrested at the late phase of larval-pupal and pupal-adult ecdysis. The majority of 
insects injected with TC005545/smo dsRNA died during the early pupal stages without 
showing any ecdysis defects. 
The GPCRs identified in this study [71] could be served as potential pesticide targets, which 
can be used in small molecule screen, or the development of RNAi-based pesticides. Among 
the identified GPCRs, many of them belong to classic GPCR families, e.g. biogenic amine 
receptors (TC007490 /D2R and TC011960/5-HTR) and neuropeptide receptors 
(TC009127/glycoprotein hormone-like receptor). These GPCRs, which are activated by small 
molecules, can be used as potential tar-gets for novel pesticide development. On the other 
hand, it may not be possible to apply small molecule ligands for pest management through 
targeting identified atypical GPCRs (e.g. TC014055 / fz and TC005545 / smo) whose ligands 
tend to be larger proteins.  However, it should be possible to develop a RNAi-based pest 
control strategy through ingestion of specific dsRNA targeting atypical GPCRs as well as 
classical GPCRs [73]. 
 
 First Screen Second Screen 
Class Official ID 
Larva 
Mortality 
Pupa 
Mortality 
 
Larva 
Mortality 
Pupa 
Mortality 
/ malE # 6.7% 0.0%  2.4% 2.4% 
Class A 
Rhodopsin-like 
TC007490 64.3% 35.7%  100.0% 0.0% 
TC008163 10.0% 90.0%  21.2% 75.8% 
TC009127 50.0% 16.7%  40.0% 0.0% 
TC006805 0.0% 62.5%  9.1% 54.5% 
TC013945 0.0% 100.0%  42.1% 52.6% 
TC012493 20.0% 60.0%  * * 
TC004716 0.0% 41.7%  38.9% 22.2% 
Class B 
Secretin receptor-
like 
TC001872 55.6% 44.4%  68.4% 31.6% 
TC009370 0.0% 90.0%  42.9% 57.1% 
TC012521 0.0% 90.0%  31.6% 68.4% 
Class D 
Atypical GPCRs 
TC014055 0.0% 100.0%  60.0% 40.0% 
TC005545 0.0% 92.3%  46.7% 53.3% 
# : E. coli malE gene is used as a negative control. 
Table 3. Summary of RNAi for 12 GPCRs in T. castaneum. Asterisk indicates that RNAi for TC012493 
was not carried out at the second screen.  
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4. Conclusion 
Genome-wide RNAi screen is a powerful technique for studying gene functions, 
deciphering complex phenotypes, and identifying novel drug targets. It opens up a whole 
new field that allows researchers to explore new modulators in classical signaling pathways, 
new mechanisms underlying basic biological functions, and new drug targets of human 
diseases. An increasing number of genome-wide RNAi screens have been successfully 
conducted for all kinds of novel discoveries. Although the off-target effects and other false 
discovery issues still remain, RNAi screen technique will be greatly improved as the 
development of new RNAi libraries and image detection instruments. Most importantly, as 
our understanding of RNAi pathway continues to grow, we will be able to design more 
specific and effective RNAi tools for genome-wide RNAi screen. There is no doubt that, 
through genome-wide RNAi screens, we will gain more insights into complex signaling 
networks and molecular mechanism of diseases in the near future, which will eventually 
lead to the discovery of novel therapeutic drug and crop protection reagents.  
Author details 
Hua Bai 
Department of Ecology and Evolutionary Biology, Brown University, USA 
Acknowledgement 
I’d like to thank Subba R. Palli and Ping Kang for valuable comments on the manuscript, 
and Ellison Medical Foundation/AFAR postdoctoral fellowship for the financial support. 
5. References 
[1] Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific 
genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998 
Feb 19;391(6669):806-11. 
[2] Mello CC, Conte D, Jr. Revealing the world of RNA interference. Nature. 2004 Sep 
16;431(7006):338-42. 
[3] Zamore PD. RNA interference: big applause for silencing in Stockholm. Cell. 2006 Dec 
15;127(6):1083-6. 
[4] Ratcliff F, Harrison BD, Baulcombe DC. A similarity between viral defense and gene 
silencing in plants. Science. 1997 Jun 6;276(5318):1558-60. 
[5] Mourrain P, Beclin C, Elmayan T, Feuerbach F, Godon C, Morel JB, et al. Arabidopsis 
SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural 
virus resistance. Cell. 2000 May 26;101(5):533-42. 
[6] Voinnet O, Lederer C, Baulcombe DC. A viral movement protein prevents spread of the 
gene silencing signal in Nicotiana benthamiana. Cell. 2000 Sep 29;103(1):157-67. 
 
Functional Genomics 108 
[7] Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, et al. Identification of 
hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005 
Jul;37(7):766-70. 
[8] Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-
nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. 
Nature. 2000 Feb 24;403(6772):901-6. 
[9] Arasu P, Wightman B, Ruvkun G. Temporal regulation of lin-14 by the antagonistic 
action of two other heterochronic genes, lin-4 and lin-28. Genes Dev. 1991 
Oct;5(10):1825-33. 
[10] Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of 
lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006 Feb;3(2):87-
98. 
[11] Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, et al. MicroRNAs 103 
and 107 regulate insulin sensitivity. Nature. 2011 Jun 30;474(7353):649-53. 
[12] Mencia A, Modamio-Hoybjor S, Redshaw N, Morin M, Mayo-Merino F, Olavarrieta L, 
et al. Mutations in the seed region of human miR-96 are responsible for nonsyndromic 
progressive hearing loss. Nat Genet. 2009 May;41(5):609-13. 
[13] He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A 
microRNA polycistron as a potential human oncogene. Nature. 2005 Jun 
9;435(7043):828-33. 
[14] Consortium CeS. Genome sequence of the nematode C. elegans: a platform for 
investigating biology. Science. 1998 Dec 11;282(5396):2012-8. 
[15] Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, et al. The 
genome sequence of Drosophila melanogaster. Science. 2000 Mar 24;287(5461):2185-95. 
[16] Friedman A, Perrimon N. A functional RNAi screen for regulators of receptor tyrosine 
kinase and ERK signalling. Nature. 2006 Nov 9;444(7116):230-4. 
[17] Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, et al. Highly 
parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A. 2008 
Dec 23;105(51):20380-5. 
[18] Pospisilik JA, Schramek D, Schnidar H, Cronin SJ, Nehme NT, Zhang X, et al. 
Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown 
versus white adipose cell fate. Cell. 2010 Jan 8;140(1):148-60. 
[19] Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. Identification 
of host proteins required for HIV infection through a functional genomic screen. 
Science. 2008 Feb 15;319(5865):921-6. 
[20] Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, et al. A systematic RNAi 
screen for longevity genes in C. elegans. Genes Dev. 2005 Jul 1;19(13):1544-55. 
[21] Hansen M, Hsu AL, Dillin A, Kenyon C. New genes tied to endocrine, metabolic, and 
dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. 
PLoS Genet. 2005 Jul;1(1):119-28. 
[22] Mohr S, Bakal C, Perrimon N. Genomic screening with RNAi: results and challenges. 
Annu Rev Biochem. 2010;79:37-64. 
Genome-Wide RNAi Screen for the Discovery of  
Gene Function, Novel Therapeutical Targets and Agricultural Applications 109 
[23] Perrimon N, Ni JQ, Perkins L. In vivo RNAi: today and tomorrow. Cold Spring Harb 
Perspect Biol. 2010 Aug;2(8):a003640. 
[24] Ramadan N, Flockhart I, Booker M, Perrimon N, Mathey-Prevot B. Design and 
implementation of high-throughput RNAi screens in cultured Drosophila cells. Nat 
Protoc. 2007;2(9):2245-64. 
[25] Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, Hemmings BA, et al. 
Use of double-stranded RNA interference in Drosophila cell lines to dissect signal 
transduction pathways. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6499-503. 
[26] Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates 
post-transcriptional gene silencing in Drosophila cells. Nature. 2000 Mar 
16;404(6775):293-6. 
[27] Kamentsky L, Jones TR, Fraser A, Bray MA, Logan DJ, Madden KL, et al. Improved 
structure, function and compatibility for CellProfiler: modular high-throughput image 
analysis software. Bioinformatics. 2011 Apr 15;27(8):1179-80. 
[28] Kiger AA, Baum B, Jones S, Jones MR, Coulson A, Echeverri C, et al. A functional 
genomic analysis of cell morphology using RNA interference. J Biol. 2003;2(4):27. 
[29] Bjorklund M, Taipale M, Varjosalo M, Saharinen J, Lahdenpera J, Taipale J. 
Identification of pathways regulating cell size and cell-cycle progression by RNAi. 
Nature. 2006 Feb 23;439(7079):1009-13. 
[30] Sims D, Duchek P, Baum B. PDGF/VEGF signaling controls cell size in Drosophila. 
Genome Biol. 2009;10(2):R20. 
[31] Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, Evans S, et al. An RNAi-based 
chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless 
signaling pathway. Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):5954-63. 
[32] Seyhan AA, Varadarajan U, Choe S, Liu Y, McGraw J, Woods M, et al. A genome-wide 
RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and 
paclitaxel combination drug treatments. Mol Biosyst. 2011 Jun;7(6):1974-89. 
[33] Zhu YX, Tiedemann R, Shi CX, Yin H, Schmidt JE, Bruins LA, et al. RNAi screen of the 
druggable genome identifies modulators of proteasome inhibitor sensitivity in 
myeloma including CDK5. Blood. 2011 Apr 7;117(14):3847-57. 
[34] Kulkarni MM, Booker M, Silver SJ, Friedman A, Hong P, Perrimon N, et al. Evidence of 
off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based 
assays. Nat Methods. 2006 Oct;3(10):833-8. 
[35] Booker M, Samsonova AA, Kwon Y, Flockhart I, Mohr SE, Perrimon N. False negative 
rates in Drosophila cell-based RNAi screens: a case study. BMC Genomics. 2011;12:50. 
[36] Bakal C, Linding R, Llense F, Heffern E, Martin-Blanco E, Pawson T, et al. 
Phosphorylation networks regulating JNK activity in diverse genetic backgrounds. 
Science. 2008 Oct 17;322(5900):453-6. 
[37] Tu Z, Argmann C, Wong KK, Mitnaul LJ, Edwards S, Sach IC, et al. Integrating siRNA 
and protein-protein interaction data to identify an expanded insulin signaling network. 
Genome Res. 2009 Jun;19(6):1057-67. 
 
Functional Genomics 110 
[38] Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, et al. A 
large-scale RNAi screen in human cells identifies new components of the p53 pathway. 
Nature. 2004 Mar 25;428(6981):431-7. 
[39] Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, et al. Integrative genomic 
approaches identify IKBKE as a breast cancer oncogene. Cell. 2007 Jun 15;129(6):1065-
79. 
[40] Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, Rodgers MA, et al. 
Discovery of insect and human dengue virus host factors. Nature. 2009 Apr 
23;458(7241):1047-50. 
[41] Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, et al. Human host 
factors required for influenza virus replication. Nature. 2010 Feb 11;463(7282):813-7. 
[42] Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT. In vivo RNAi screening 
identifies regulators of actin dynamics as key determinants of lymphoma progression. 
Nat Genet. 2009 Oct;41(10):1133-7. 
[43] Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, Krasnitz A, et al. Functional 
identification of tumor-suppressor genes through an in vivo RNA interference screen in 
a mouse lymphoma model. Cancer Cell. 2009 Oct 6;16(4):324-35. 
[44] Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. 
Functional genomic analysis of C. elegans chromosome I by systematic RNA 
interference. Nature. 2000 Nov 16;408(6810):325-30. 
[45] Dillin A, Hsu AL, Arantes-Oliveira N, Lehrer-Graiwer J, Hsin H, Fraser AG, et al. Rates 
of behavior and aging specified by mitochondrial function during development. 
Science. 2002 Dec 20;298(5602):2398-401. 
[46] Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. A systematic RNAi 
screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet. 2003 
Jan;33(1):40-8. 
[47] Wang MC, O'Rourke EJ, Ruvkun G. Fat metabolism links germline stem cells and 
longevity in C. elegans. Science. 2008 Nov 7;322(5903):957-60. 
[48] Parry DH, Xu J, Ruvkun G. A whole-genome RNAi Screen for C. elegans miRNA 
pathway genes. Curr Biol. 2007 Dec 4;17(23):2013-22. 
[49] Maeda I, Kohara Y, Yamamoto M, Sugimoto A. Large-scale analysis of gene function in 
Caenorhabditis elegans by high-throughput RNAi. Curr Biol. 2001 Feb 6;11(3):171-6. 
[50] Ni JQ, Markstein M, Binari R, Pfeiffer B, Liu LP, Villalta C, et al. Vector and parameters 
for targeted transgenic RNA interference in Drosophila melanogaster. Nat Methods. 
2008 Jan;5(1):49-51. 
[51] Saj A, Arziman Z, Stempfle D, van Belle W, Sauder U, Horn T, et al. A combined ex 
vivo and in vivo RNAi screen for notch regulators in Drosophila reveals an extensive 
notch interaction network. Dev Cell. 2010 May 18;18(5):862-76. 
[52] Cronin SJ, Nehme NT, Limmer S, Liegeois S, Pospisilik JA, Schramek D, et al. Genome-
wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. 
Science. 2009 Jul 17;325(5938):340-3. 
Genome-Wide RNAi Screen for the Discovery of  
Gene Function, Novel Therapeutical Targets and Agricultural Applications 111 
[53] Neely GG, Kuba K, Cammarato A, Isobe K, Amann S, Zhang L, et al. A global in vivo 
Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. 
Cell. 2010 Apr 2;141(1):142-53. 
[54] Neely GG, Hess A, Costigan M, Keene AC, Goulas S, Langeslag M, et al. A genome-
wide Drosophila screen for heat nociception identifies alpha2delta3 as an evolutionarily 
conserved pain gene. Cell. 2010 Nov 12;143(4):628-38. 
[55] Neumuller RA, Richter C, Fischer A, Novatchkova M, Neumuller KG, Knoblich JA. 
Genome-wide analysis of self-renewal in Drosophila neural stem cells by transgenic 
RNAi. Cell Stem Cell. 2011 May 6;8(5):580-93. 
[56] Fernandes C, Rao Y. Genome-wide screen for modifiers of Parkinson's disease genes in 
Drosophila. Mol Brain. 2011;4:17. 
[57] Lee SS. Whole genome RNAi screens for increased longevity: important new insights 
but not the whole story. Exp Gerontol. 2006 Oct;41(10):968-73. 
[58] Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives 
twice as long as wild type. Nature. 1993 Dec 2;366(6454):461-4. 
[59] Kaeberlein M, Powers RW, 3rd, Steffen KK, Westman EA, Hu D, Dang N, et al. 
Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. 
Science. 2005 Nov 18;310(5751):1193-6. 
[60] Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein 
kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. 
Genes Dev. 2004 Dec 15;18(24):3004-9. 
[61] Paik D, Jang YG, Lee YE, Lee YN, Yamamoto R, Gee HY, et al. Misexpression screen 
delineates novel genes controlling Drosophila lifespan. Mech Ageing Dev. 2012 Feb 24. 
[62] Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, et al. 
Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature. 2007 
Apr 12;446(7137):815-9. 
[63] Tomoyasu Y, Denell RE. Larval RNAi in Tribolium (Coleoptera) for analyzing adult 
development. Dev Genes Evol. 2004 Nov;214(11):575-8. 
[64] Sanchez-Vargas I, Travanty EA, Keene KM, Franz AW, Beaty BJ, Blair CD, et al. RNA 
interference, arthropod-borne viruses, and mosquitoes. Virus Res. 2004 Jun 1;102(1):65-
74. 
[65] Nunes FM, Simoes ZL. A non-invasive method for silencing gene transcription in 
honeybees maintained under natural conditions. Insect Biochem Mol Biol. 2009 
Feb;39(2):157-60. 
[66] Shakesby AJ, Wallace IS, Isaacs HV, Pritchard J, Roberts DM, Douglas AE. A water-
specific aquaporin involved in aphid osmoregulation. Insect Biochem Mol Biol. 2009 
Jan;39(1):1-10. 
[67] Zhou X, Wheeler MM, Oi FM, Scharf ME. RNA interference in the termite 
Reticulitermes flavipes through ingestion of double-stranded RNA. Insect Biochem Mol 
Biol. 2008 Aug;38(8):805-15. 
[68] Baum JA, Bogaert T, Clinton W, Heck GR, Feldmann P, Ilagan O, et al. Control of 
coleopteran insect pests through RNA interference. Nat Biotechnol. 2007 
Nov;25(11):1322-6. 
 
Functional Genomics 112 
[69] Mao YB, Cai WJ, Wang JW, Hong GJ, Tao XY, Wang LJ, et al. Silencing a cotton 
bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval tolerance 
of gossypol. Nat Biotechnol. 2007 Nov;25(11):1307-13. 
[70] Richards S, Gibbs RA, Weinstock GM, Brown SJ, Denell R, Beeman RW, et al. The 
genome of the model beetle and pest Tribolium castaneum. Nature. 2008 Apr 
24;452(7190):949-55. 
[71] Bai H, Zhu F, Shah K, Palli SR. Large-scale RNAi screen of G protein-coupled receptors 
involved in larval growth, molting and metamorphosis in the red flour beetle. BMC 
Genomics. 2011;12:388. 
[72] Bai H, Palli SR. Functional characterization of bursicon receptor and genome-wide 
analysis for identification of genes affected by bursicon receptor RNAi. Dev Biol. 2010 
Aug 1;344(1):248-58. 
[73] Price DR, Gatehouse JA. RNAi-mediated crop protection against insects. Trends 
Biotechnol. 2008 Jul;26(7):393-400. 
